2nd Quarter - Report

HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) for HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)

Firm
Client
Income
—
Expenses
$272,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Debt Ceiling Negotiations; Full-Year Continuing Appropriations Act 2011 (H.R. 1); Final Fiscal Year 2011 Continuing Resolution (H.R. 1473)

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach, Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY —
THOMAS PHAN Professional Staff, Senate Aging Committee

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (112th), H.R. 1473 (112th)

Taxation/Internal Revenue Code TAX

LIFO Accounting Methodology; 1099 Reporting Requirement (H.R. 4, H.R. 705)

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach, Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 705 (112th), H.R. 4 (112th)

Medicare/Medicaid MMM

Average Sales Price (H.R. 905/S. 733)

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach, Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY —
THOMAS PHAN Professional Staff, Senate Aging Committee

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: S. 733 (112th), H.R. 905 (112th)

Pharmacy PHA

Importation of prescription drugs (S. 319, H.R. 147); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation; NASPER Reauthorization (H.R. 866); Pill Mill Crackdown Act (H.R. 1065); Drug Abuse (S. 507); Drug Shortages (S. 296/H.R. 2245); Cargo/Product Theft (S. 1002); Issues related to DEA drug diversion programs

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach, Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 147 (112th), S. 319 (112th), H.R. 866 (112th), S. 507 (112th), H.R. 1065 (112th), H.R. 2245 (112th), S. 296 (112th), S. 1002 (112th)

Affiliated organisations

OrganisationLocation
AMERISOURCEBERGEN DRUG COMPANY Valley Forge, PA, US
CARDINAL HEALTH, INC Dublin, OH, US
MCKESSON CORPORATION San Francisco, CA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.